Betta Pharmaceuticals

China

FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
3 approved
2 in Phase 2
Next date
BPI-371153, Phase 1 trial completes
Drugs
10
in active trials · 19 in all
Trials
14 active
35 since 2021

Drugs10

DrugHow it worksPartnerStageNext dateDetails
Tyrosine kinase inhibitor
Approved in China 30 Apr 2028Phase 3 trial completes
Tyrosine kinase inhibitor
Approved in China 30 Apr 2028Phase 3 trial completes
ALK inhibitor
Xcovery
Approved 1 Feb 2029Phase 1/2 trial completes
—
Phase 2 30 Apr 2028Phase 1/2 trial completes
—
Phase 1/2 28 Dec 2028Phase 1/2 trial completes
—
Phase 1 Dec 2026Phase 1 trial completes
—
Phase 1 Jan 2027Phase 1 trial completes
—
Phase 1 Jun 2027Phase 1 trial completes
—
Phase 1 —
—
Phase 1 —

About

No active trial
9 other drugs
SEC filings
None: it does not file with the US SEC
Sources
ClinicalTrials.gov updated 16 Nov 2026 Industry-sponsored drug trials since 2021

Follow Betta Pharmaceuticals

Following is part of Solo: you see every change to Betta Pharmaceuticals the day it happens.

Solo

$49a month

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in